Latham & Watkins advised Skydance and the Investor Group on the transaction; Sullivan & Cromwell advised RedBird Capital Partners; Ropes & Gray advised National Amusements; Cravath,...
You must be a Standard 1 Year member to access this content.
Cravath Swaine & Moore is representing Viatris in the transaction. Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Idorsia Ltd (SIX: IDIA) announced they have entered...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
You must be a Standard 1 Year member to access this content.
Cravath Swaine & Moore represented IBM in the transaction. Technip Energies (PARIS: TE) (ISIN:NL0014559478) announced the launch of Reju, a new company focused on PET (Polyethylene terephthalate)...
You must be a Standard 1 Year member to access this content.
Cravath, alongside Slaughter and May, AZB & Partners and NautaDutilh, is representing Route Mobile and its founding shareholders in connection with the transaction. On July 17,...
You must be a Standard 1 Year member to access this content.
Cravath represented IBM in connection with the transaction. IBM announced it has acquired Polar Security, an innovator in technology that helps companies discover, continuously monitor and...
You must be a Standard 1 Year member to access this content.
Cravath represented Disney in the transaction. The Walt Disney Company (“Disney”) issued a statement in response to Nelson Peltz’s announcement that Trian Fund is no longer...
You must be a Standard 1 Year member to access this content.
Cravath represented IBM in connection with the transaction while Morrison Foerster served as government contracts and regulatory counsel to Octo. IBM announced an agreement to acquire...
You must be a Standard 1 Year member to access this content.
Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore advised Atlas Air Worldwide, Paul, Weiss, Rifkind, Wharton & Garrison advised Apollo and the Consortium entity, and Jones Day advised J.F. Lehman...
You must be a Standard 1 Year member to access this content.
Cravath represented IBM in the transaction. IBM announced it plans to acquire Randori, a leading attack surface management and offensive cybersecurity provider. Recognized as a leader...
You must be a Standard 1 Year member to access this content.
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
You must be a Standard 1 Year member to access this content.
